We are live on ! Find out more
IE

Israel Englander Millennium Management

AUM $276B
1-Year Est. Return 44.8%
 

Israel “Izzy” Englander is the founder of Millennium Management, one of the world’s largest multi-strategy hedge fund platforms. Millennium allocates capital across hundreds of independent teams rather than a single house view, with rigorous risk controls at the platform level. Englander’s model has been highly influential in the rise of pod-shop multi-manager structures across the industry.

This Fund
S&P 500
This Quarter Est. Return
+17.55%
1 Year Est. Return
+44.8%
3 Year Est. Return
+127.22%
5 Year Est. Return
+155.52%
10 Year Est. Return
+768.06%
AUM
$66.8B
AUM Growth
+$2.68B
Cap. Flow
-$6.14B
Cap. Flow %
-9.19%
Top 10 Hldgs %
7.07%
Holding
4,608
New
914
Increased
1,493
Reduced
1,467
Closed
675

Top Buys

Rank Stock Value
1
DIS icon
Walt Disney
DIS
+$655M
2
COTY icon
Coty
COTY
+$380M
3
COP icon
ConocoPhillips
COP
+$250M
4
ZBH icon
Zimmer Biomet
ZBH
+$213M
5
VLO icon
Valero Energy
VLO
+$170M

Top Sells

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$523M
2
MRK icon
Merck
MRK
+$375M
3
SHPG
Shire pic
SHPG
+$362M
4
GOOG icon
Alphabet (Google) Class C
GOOG
+$310M
5
CELG
Celgene Corp
CELG
+$286M

Sector Composition

Rank Sector Weight
1 Healthcare 13.57%
2 Technology 12.05%
3 Financials 10.74%
4 Consumer Discretionary 9.44%
5 Energy 8.19%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
AGFSW
3901
DELISTED
AgroFresh Solutions Inc Warrants
AGFSW
$14K ﹤0.01%
150,000
VANI icon
3902
Vivani Medical
VANI
$122M
$13K ﹤0.01%
699
-47
-6% -$915
ASM
3903
Avino Silver & Gold Mines
ASM
$1.25B
$11K ﹤0.01%
17,700
UAMY icon
3904
United States Antimony
UAMY
$756M
$9K ﹤0.01%
+19,487
New +$11.1K
GSAH.WS
3905
DELISTED
GS Acquisition Holdings Corp Warrants, each whole warrant exercisable for one share of Class A Commo
GSAH.WS
$9K ﹤0.01%
16,666
GMO
3906
DELISTED
General Moly, Inc.
GMO
$3K ﹤0.01%
13,930
+3,111
+29% +$763
OCGN icon
3907
Ocugen
OCGN
$451M
$1K ﹤0.01%
184
-2,306
-93% -$19.7K
AC
3908
DELISTED
Associated Capital Group
AC
-6,577
Closed -$231K
ACB
3909
Aurora Cannabis
ACB
$245M
-2,127
Closed -$1.27M
ACN icon
3910
Accenture
ACN
$114B
-450,702
Closed -$70.8M
ACP
3911
abrdn Income Credit Strategies Fund
ACP
$631M
-35,047
Closed -$355K
ADAP
3912
CALL
DELISTED
Adaptimmune Therapeutics
ADAP
-200,000
Closed -$1.15M
ADVM
3913
DELISTED
Adverum Biotechnologies
ADVM
-8,922
Closed -$281K
AEO icon
3914
American Eagle Outfitters
AEO
$2.78B
-1,103,180
Closed -$21.3M
AER icon
3915
AerCap
AER
$23.1B
-5,900
Closed -$234K
AG icon
3916
First Majestic Silver
AG
$10.3B
-23,006
Closed -$136K
AGIO icon
3917
Agios Pharmaceuticals
AGIO
$1.96B
-215,902
Closed -$9.96M
AGMH icon
3918
AGM Group Holdings
AGMH
$5.04M
-245
Closed -$326K
AKTX
3919
Akari Therapeutics
AKTX
$15.2M
-34
Closed -$43K
ALLK
3920
DELISTED
Allakos
ALLK
-7,748
Closed -$405K
ALNY icon
3921
Alnylam Pharmaceuticals
ALNY
$31.1B
-11,373
Closed -$829K
ALNT icon
3922
Allient
ALNT
$1.62B
-18,404
Closed -$548K
ALTO icon
3923
Alto Ingredients
ALTO
$327M
-79,793
Closed -$69K
ALX
3924
Alexander's
ALX
$1.36B
-2,401
Closed -$732K
ALV icon
3925
Autoliv
ALV
$9.1B
-8,581
Closed -$603K

Similar funds

Israel Englander's Q1 2019 Portfolio in Review

As of Q1 2019, Israel Englander held 4,608 positions worth $66.8B, up 4.2% from $64.1B the previous quarter. Its ten largest holdings account for 7.1% of the portfolio.

Israel Englander withdrew a net $6.14B in Q1 2019, closing 675 positions and reducing 1,467 holdings. Its most notable exit was Merck, an estimated $375M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 14% of assets, down from 14% a quarter earlier, followed by Technology and Financials.

Against the trend, Israel Englander opened a new position in Zimmer Biomet worth $232M.

  • Israel Englander's largest Q1 2019 buy was Zimmer Biomet: 1,870,503 shares worth $232M.
  • Israel Englander added most to Walt Disney in Q1 2019, an estimated $655M increase.
  • Israel Englander's biggest Q1 2019 reduction was Apple, cutting an estimated $523M.
  • Israel Englander fully exited Merck in Q1 2019, selling an estimated $375M.
  • Israel Englander's ten largest holdings make up 7.1% of its $66.8B portfolio in Q1 2019.
  • Israel Englander opened 914 new positions and closed 675 in Q1 2019.
  • Israel Englander's portfolio value rose 4.2% quarter-over-quarter to $66.8B.

Based on Millennium Management's 13F filing for Q1 2019, filed 14 May 2019.